Author

Christopher Tse

University of California, Los Angeles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

David A. NathansoniD· 3 shared Aparna BhaduriiD· 2 shared Brittney D WickiD· 2 shared Daria J. AzizadiD· 2 shared Dimitri CadetiD· 2 shared Elisa FazzariiD· 2 shared Hong A. TumiD· 2 shared Kunal S. PateliD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

David A. NathansonORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastoma

Elisa Fazzari, Daria J. Azizad, Matthew X. Li, Weihong Ge, Shivani Baisiwala, Dimitri Cadet, Patricia R. Nano, Ryan L. Kan, Travis Perryman, Hong A. Tum, Christopher Tse, Brittney D Wick, Carolina Varona-Arguelles, Kunal S. Patel, Linda M. Liau, , Aparna Bhaduri

The paper maps clonal hierarchies in glioblastoma using lineage-resolved single-cell data, revealing multiple non-redundant progenitors and identifying cell type-specific therapeutic targets.

bioRxiv · Feb 23, 2026 · PreprintCancer Biology

Beyond Cell Cycle Control: CDKN2A Loss Orchestrates NAD⁺ Metabolic Plasticity and NAMPT Inhibitor Sensitivity in Glioblastoma

Swati Dubey, Guanqiao Yu, Ryana Aboul-Hosn, Christopher Tse, David A. Nathanson, Albert Lai, Keith A. Vossel, Fausto J. Rodríguez

The paper shows CDKN2A loss in glioblastoma affects NAD+ metabolism and increases sensitivity to NAMPT inhibitors, beyond its role in cell cycle control.

bioRxiv · Dec 4, 2025 · PreprintCancer Biology

A neurovascular progenitor sits at the nexus of glioblastoma lineage trajectories

Elisa Fazzari, Daria J. Azizad, Kwanha Yu, Weihong Ge, Matthew X. Li, Patricia R. Nano, Shivani Baisiwala, Antoni Andreu Martija, Ryan L. Kan, Jaela Caston, Loukas N. Diafos, Hong A. Tum, Christopher Tse, Nicholas A. Bayley, Vjola Haka, , Aparna Bhaduri

This study identifies a neurovascular progenitor cell type in glioblastoma that links distinct malignant lineages and influences tumor composition and survival.

bioRxiv · Jul 24, 2024 · PreprintCancer Biology